Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Endo Pharmaceuticals Inc. et al v. Noven Pharmaceuticals Inc.
Case Number:
1:12-cv-00831
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 17, 2014
Endo, Noven Ink Settlement Over Lidoderm Patch Patent
Endo Pharmaceuticals Inc. said Thursday that it had reached a licensing agreement with undisclosed terms with Noven Pharmaceuticals Inc., settling a patent suit in Delaware federal court over Noven's bid to make and sell a generic version of the Lidoderm adhesive lidocaine pain patch.
-
June 29, 2012
Endo Sues Noven To Protect The Market For Lidoderm
Endo Pharmaceuticals Inc. hit Noven Pharmaceuticals Inc. with a patent suit in Delaware on Friday over Noven's recent bid for U.S. regulatory approval to make and sell a generic version of the Lidoderm adhesive lidocaine pain patch.